CRI and Mark Foundation Launch ctDNA Clinical Trial The Phase 2 clinical trial will analyze blood-based biomarkers versus conventional radiography for cancer patients treated with... July 28, 2020July 13, 2022
CRI Statement on Blackbaud Data Breach The Cancer Research Institute (CRI) was informed on July 16, 2020, that one of our vendors, Blackbaud, experienced a data... July 27, 2020July 13, 2022
Eighth Annual Cancer Immunotherapy Month™ 30 days of immunotherapy education and awareness programming for patients, caregivers, and the others celebrating advances in... June 1, 2020July 13, 2022
Rapid Growth in Cancer Cellular Immunotherapies Report reveals that the cellular immunotherapy landscape continues to expand, with 472 more cellular therapies in development... May 26, 2020July 13, 2022
Impact of COVID-19 on Oncology Clinical Trials Results of recent survey of clinical trial investigators in United States, Europe, and Asia together with analysis... May 18, 2020July 13, 2022
Steven A. Rosenberg Recognized With 2020 AACR-CRI Lloyd J. Old Award The American Association for Cancer Research (AACR) will present Steven A. Rosenberg, MD, PhD, Fellow of the... May 11, 2020July 13, 2022